Informație de încredere. Sprijin real.

Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.

Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

Afecțiuni neurologice

Evaluare Psihologica

Ca stim de unde pornim

Programeaza o evaluare

Articole și ghiduri recomandate

PresăDepresieÎncredere bună15.06.2026

Depression may involve impaired energy production in brain cells

Research reveals that brain and blood cells in people with major depressive disorder show abnormal energy metabolism—producing excess energy molecules at rest but failing to scale up production when needed. This cellular energy dysregulation may underlie depression symptoms like fatigue and low motivation, offering potential insights for diagnosis and treatment development.

PresăDepresieÎncredere bună15.06.2026

Adolescent Diet Patterns Associated with Mental Health Outcomes: A Review of Research

A meta-review of approximately 20 studies indicates that whole dietary patterns correlate with adolescent mental health, with healthier diets associated with fewer depressive symptoms and poor eating habits linked to greater psychological distress. The research emphasizes holistic dietary patterns over isolated nutrients as more consistently beneficial during critical neurodevelopmental periods.

PresăDepresieÎncredere bună15.06.2026

Harvard scientists link gut bacteria to depression through hidden inflammation trigger

Researchers identified that Morganella morganii, a gut bacterium, produces an inflammation-triggering molecule when exposed to common pollutants, potentially contributing to depression via immune mechanisms. The discovery suggests new treatment approaches targeting immune system pathways rather than exclusively targeting brain chemistry.

PresăAutism + ADHDÎncredere bună15.06.2026

GLP-1 Drugs Linked to Lower Depression and Anxiety Risk in Large Long-Term Study

A decade-long study of nearly 100,000 people found that GLP-1 receptor agonist drugs like semaglutide (Ozempic/Wegovy) were associated with significantly reduced psychiatric hospital visits and fewer sick days. While the mechanism remains unclear, these findings suggest potential mental health benefits alongside the known metabolic effects of these medications.